Diagnosis
Important factors in diagnosing BPD are prematurity, infection, mechanical ventilator dependence, and oxygen exposure.
BPD is typically diagnosed if an infant still requires additional oxygen and continues to show signs of respiratory problems after 28 days of age (or past 36 weeks' postconceptional age). Chest X-rays may be helpful in making the diagnosis. In babies with RDS, the X-rays may show lungs that look like ground glass. In babies with BPD, the X-rays may show lungs that appear spongy.
Treatment of BPD
No available medical treatment can immediately cure bronchopulmonary dysplasia. Treatment is geared to support the breathing and oxygen needs of infants with BPD and to enable them to grow and thrive.
Babies first diagnosed with BPD receive intense supportive care in the hospital, usually in a newborn intensive care unit (NICU) until they are able to breathe well enough on their own without the support of a mechanical ventilator.
Some babies also may receive jet ventilation, a continuous low-pressure ventilation that helps minimize the lung damage from ventilation that contributes to BPD. Not all hospitals use this procedure to treat BPD, but some hospitals with large NICUs do.
Infants with BPD are also treated with different kinds of medications that help to support lung function. These include bronchodilators (such as albuterol) to help keep the airways open, and diuretics (such as furosemide) to reduce fluid buildup in the lungs.
Severe cases of BPD might be treated with a short course of steroids. This strong anti-inflammation medicine has some serious short-term and long-term side effects. Doctors would only use it after a discussion with you, informing you of the potential benefits and risks of the drug.
Antibiotics are sometimes needed to fight bacterial infections because babies with BPD are more likely to develop pneumonia. Part of a baby's treatment may involve the administration of surfactant, a natural lubricant that improves breathing function. Babies with RDS who have not yet been diagnosed with BPD may have disrupted surfactant production, so administering natural or synthetic surfactant may reduce the chance that BPD develops.
In addition, babies sick enough to be hospitalized with BPD may need feedings of high-calorie formulas through a gastric tube inserted into the stomach to ensure they get enough calories and nutrients and start to grow.
In severe cases, babies with BPD cannot use their gastrointestinal systems to digest food. These babies require intravenous (IV) feedings — called TPN, or total parenteral nutrition — made up of fats, proteins, sugars, and nutrients. These are given through a small tube inserted into a large vein through the baby's skin.
The time spent in the NICU for infants with BPD can range from several weeks to a few months. The National Institutes of Health (NIH) estimates that the average length of intensive in-hospital care for babies with BPD is 120 days. Even after leaving the hospital, a baby might require continued medication, breathing treatments, or even oxygen at home.
Most children are weaned from supplemental oxygen by the end of their first year, but a few with serious cases may need a ventilator for several years or even their entire lives (although this is rare).
Improvement for any baby with BPD is gradual. Some infants will be slow to improve; others may not recover from the condition if their lung disease is very severe. Lungs continue to grow for 5-7 years, and there can be subtle abnormal lung function even at school age in some cases.
Many babies diagnosed with BPD will recover close to normal lung function, but this takes time. Scarred, stiffened lung tissue will always have poor function. However, as infants with BPD grow, new healthy lung tissue can form and grow, and might eventually take over much of the work of breathing for diseased lung tissue.